W. Shih

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor (GRM1) signaling, in advanced melanoma.

James S Goydos, Y. Wen, J. Lee, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.